Programme / Speakers
14:00 – 14:30: Droplet Microfluidics with Mass Spectrometry for High-Throughput Enzyme Reaction Analysis
Prof. Dr. Robert T. Kennedy
Department of Chemistry, University of Michigan, Ann Abor, MI 48109, USA
14:30 – 15:00: Biomolecular engineeDroplets-on-demand platforms for the high-throughput characterisation of functional enzymes
Dr. Fabrice Gielen
Department of Physics, Living Systems Institute, University of Exeter, UK
15:00 – 15:30: Measuring Enzyme Kinetics, Inhibition, and Allostery using Isothermal Titration Calorimetry
Prof. Dr. Anthony K. Mittermaier
Department of Chemistry, McGill University, Montreal, QC, Canada
15:30 – 16:00: Redesign of oxidative enzymes for the biocatalytic valorisIdentification of diverse enzymes by screening biodiversity using innovative in silico approaches: example with the Amine Dehydrogenase family (MODAMDH Project)
Dr. Carine Vergne-Vaxelaire
Génomique Métabolique UMR8030, Genoscope, CEA, Univ Evry, Université Paris-Saclay, France
Abstracts and Short Bios of the speakers
Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.
Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.
Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.
The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.
Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.
Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.